These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

465 related items for PubMed ID: 15048706

  • 1. Comparative analysis of human NK cell activation induced by NKG2D and natural cytotoxicity receptors.
    André P, Castriconi R, Espéli M, Anfossi N, Juarez T, Hue S, Conway H, Romagné F, Dondero A, Nanni M, Caillat-Zucman S, Raulet DH, Bottino C, Vivier E, Moretta A, Paul P.
    Eur J Immunol; 2004 Apr; 34(4):961-71. PubMed ID: 15048706
    [Abstract] [Full Text] [Related]

  • 2. NKG2D recruits two distinct adapters to trigger NK cell activation and costimulation.
    Gilfillan S, Ho EL, Cella M, Yokoyama WM, Colonna M.
    Nat Immunol; 2002 Dec; 3(12):1150-5. PubMed ID: 12426564
    [Abstract] [Full Text] [Related]

  • 3. Selective associations with signaling proteins determine stimulatory versus costimulatory activity of NKG2D.
    Diefenbach A, Tomasello E, Lucas M, Jamieson AM, Hsia JK, Vivier E, Raulet DH.
    Nat Immunol; 2002 Dec; 3(12):1142-9. PubMed ID: 12426565
    [Abstract] [Full Text] [Related]

  • 4. Natural killer cell signaling pathways.
    Vivier E, Nunès JA, Vély F.
    Science; 2004 Nov 26; 306(5701):1517-9. PubMed ID: 15567854
    [Abstract] [Full Text] [Related]

  • 5. Major histocompatibility complex class I-related chain A and UL16-binding protein expression on tumor cell lines of different histotypes: analysis of tumor susceptibility to NKG2D-dependent natural killer cell cytotoxicity.
    Pende D, Rivera P, Marcenaro S, Chang CC, Biassoni R, Conte R, Kubin M, Cosman D, Ferrone S, Moretta L, Moretta A.
    Cancer Res; 2002 Nov 01; 62(21):6178-86. PubMed ID: 12414645
    [Abstract] [Full Text] [Related]

  • 6. Contrasting roles of DAP10 and KARAP/DAP12 signaling adaptors in activation of the RBL-2H3 leukemic mast cell line.
    Anfossi N, Lucas M, Diefenbach A, Bühring HJ, Raulet D, Tomasello E, Vivier E.
    Eur J Immunol; 2003 Dec 01; 33(12):3514-22. PubMed ID: 14635062
    [Abstract] [Full Text] [Related]

  • 7. KARAP/DAP12/TYROBP: three names and a multiplicity of biological functions.
    Tomasello E, Vivier E.
    Eur J Immunol; 2005 Jun 01; 35(6):1670-7. PubMed ID: 15884055
    [Abstract] [Full Text] [Related]

  • 8. Soluble ULBP suppresses natural killer cell activity via down-regulating NKG2D expression.
    Song H, Kim J, Cosman D, Choi I.
    Cell Immunol; 2006 Jan 01; 239(1):22-30. PubMed ID: 16630603
    [Abstract] [Full Text] [Related]

  • 9. Versatile signaling through NKG2D.
    Long EO.
    Nat Immunol; 2002 Dec 01; 3(12):1119-20. PubMed ID: 12447364
    [No Abstract] [Full Text] [Related]

  • 10. A novel ligand for the NKG2D receptor activates NK cells and macrophages and induces tumor immunity.
    Diefenbach A, Hsia JK, Hsiung MY, Raulet DH.
    Eur J Immunol; 2003 Feb 01; 33(2):381-91. PubMed ID: 12645935
    [Abstract] [Full Text] [Related]

  • 11. Enhancement of natural killer (NK) cell cytotoxicity by fever-range thermal stress is dependent on NKG2D function and is associated with plasma membrane NKG2D clustering and increased expression of MICA on target cells.
    Ostberg JR, Dayanc BE, Yuan M, Oflazoglu E, Repasky EA.
    J Leukoc Biol; 2007 Nov 01; 82(5):1322-31. PubMed ID: 17711975
    [Abstract] [Full Text] [Related]

  • 12. Intracellular signaling by the killer immunoglobulin-like receptors and Ly49.
    McVicar DW, Burshtyn DN.
    Sci STKE; 2001 Mar 27; 2001(75):re1. PubMed ID: 11752646
    [Abstract] [Full Text] [Related]

  • 13. NKG2D-mediated activation of cytotoxic lymphocytes: unique signaling pathways and distinct functional outcomes.
    Upshaw JL, Leibson PJ.
    Semin Immunol; 2006 Jun 27; 18(3):167-75. PubMed ID: 16723257
    [Abstract] [Full Text] [Related]

  • 14. Natural killer cells ameliorate liver fibrosis by killing activated stellate cells in NKG2D-dependent and tumor necrosis factor-related apoptosis-inducing ligand-dependent manners.
    Radaeva S, Sun R, Jaruga B, Nguyen VT, Tian Z, Gao B.
    Gastroenterology; 2006 Feb 27; 130(2):435-52. PubMed ID: 16472598
    [Abstract] [Full Text] [Related]

  • 15. NKG2D and Related Immunoreceptors.
    Strong RK, McFarland BJ.
    Adv Protein Chem; 2004 Feb 27; 68():281-312. PubMed ID: 15500864
    [Abstract] [Full Text] [Related]

  • 16. Rat NKp46 activates natural killer cell cytotoxicity and is associated with FcepsilonRIgamma and CD3zeta.
    Westgaard IH, Berg SF, Vaage JT, Wang LL, Yokoyama WM, Dissen E, Fossum S.
    J Leukoc Biol; 2004 Dec 27; 76(6):1200-6. PubMed ID: 15356098
    [Abstract] [Full Text] [Related]

  • 17. Natural killer cell-mediated lysis of hepatoma cells via specific induction of NKG2D ligands by the histone deacetylase inhibitor sodium valproate.
    Armeanu S, Bitzer M, Lauer UM, Venturelli S, Pathil A, Krusch M, Kaiser S, Jobst J, Smirnow I, Wagner A, Steinle A, Salih HR.
    Cancer Res; 2005 Jul 15; 65(14):6321-9. PubMed ID: 16024634
    [Abstract] [Full Text] [Related]

  • 18. A transmembrane-anchored rat RAE-1-like transcript as a ligand for NKR-P2, the rat ortholog of human and mouse NKG2D.
    Savithri B, Khar A.
    Eur J Immunol; 2006 Jan 15; 36(1):107-17. PubMed ID: 16323246
    [Abstract] [Full Text] [Related]

  • 19. Expression of the NKG2D ligand UL16 binding protein-1 (ULBP-1) on dendritic cells.
    Schrama D, Terheyden P, Otto K, Kämmerer U, Bröcker EB, Lühder F, Cosman D, Andersen MH, Becker JC.
    Eur J Immunol; 2006 Jan 15; 36(1):65-72. PubMed ID: 16342232
    [Abstract] [Full Text] [Related]

  • 20. Ligands for the murine NKG2D receptor: expression by tumor cells and activation of NK cells and macrophages.
    Diefenbach A, Jamieson AM, Liu SD, Shastri N, Raulet DH.
    Nat Immunol; 2000 Aug 15; 1(2):119-26. PubMed ID: 11248803
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 24.